2015
DOI: 10.1111/liv.12750
|View full text |Cite
|
Sign up to set email alerts
|

Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma

Abstract: Single-session SIRT appeared to be as safe and had a similar impact on HRQoL as multiple sessions of TACE, suggesting that SIRT might be an alternative option for patients eligible for TACE.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
97
0
4

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 139 publications
(102 citation statements)
references
References 27 publications
1
97
0
4
Order By: Relevance
“…Compared with TACE, radioembolization has a similar or even better objective response rate and similar survival statistics (60). Moreover, as previously discussed, PVT and bilidigestive anastomoses are no absolute contraindication.…”
Section: Clinical Outcome and Tumor Responsementioning
confidence: 72%
See 1 more Smart Citation
“…Compared with TACE, radioembolization has a similar or even better objective response rate and similar survival statistics (60). Moreover, as previously discussed, PVT and bilidigestive anastomoses are no absolute contraindication.…”
Section: Clinical Outcome and Tumor Responsementioning
confidence: 72%
“…In the intermediate and early-advanced stages of HCC (respectively, BCLC B and BCLC C), radioembolization has shown favorable outcomes compared with the currently preferred treatments (59,60). Compared with TACE, radioembolization has a similar or even better objective response rate and similar survival statistics (60).…”
Section: Clinical Outcome and Tumor Responsementioning
confidence: 99%
“…All of the articles were published between 2009 and 2016 and included with nine observational studies 13,16-23 and two RCTs 14,15 . The locations of the studies included Germany, Spain, China, Egypt, Turkey, and the USA.…”
Section: Resultsmentioning
confidence: 99%
“…The risk of bias was assessed using the Cochrane Collaboration tool for two RCTs ( Figure 2 ). One RCT, with more than two high-risk components, was considered to have a moderate risk of bias 15 , and another RCT was determined to have a low risk of bias 14 . …”
Section: Resultsmentioning
confidence: 99%
“…A retrospective case series has found similar major and minor complication rates between TACE and TARE, but greater hospitalization for both initial procedure and readmission, and worse postembolization syndrome, with TACE [53]. There is no published cost-effectiveness study on use of Y-90 TARE for HCC; a small www.karger.com/lic © 2018 S. Karger AG, Basel DOI: 10.1159/000485984 randomized trial that evaluated health-related quality of life of patients with unresectable HCC did not find a significant difference between TACE and Y-90 TARE [54]. 34.…”
Section: Tace Should Be Stopped When There Is Absence Of Viable Tumormentioning
confidence: 99%